Repaglinide for type 2 diabetes mellitus

Article Abstract:

The FDA has approved the drug repaglinide for the treatment of type 2, or adult onset, diabetes. Sold under the trade name Prandin, its effects are similar to the sulfonylureas. It can be used alone or with metformin. In fact, metformin and repaglinide appear to be more effective together than either drug used alone. As with most diabetes drugs, repaglinide should only be used when blood sugar cannot be controlled by diet and exercise.

Evaluation, Product/Service Evaluation, Prandin (Medication)

---

Miglitol for type 2 diabetes mellitus

Article Abstract:

The FDA has approved the drug miglitol for the treatment of type 2, or adult-onset, diabetes. Sold under the trade name Glyset, the drug has a similar action to acarbose (Precose). It inhibits enzymes called alpha-glucosidases, which delays the absorption of glucose in the gastrointestinal tract. It is as effective as acarbose in controlling blood sugar when used with a proper diet or with a sulfonylurea drug.

Product introduction, Glyset (Medication)

---

Similar abstracts:

• Abstracts: Smoking and type 2 diabetes in men. Smoking and kidney function in persons without diabetes. Size at birth, growth in childhood, and the risk for type 2 diabetes
• Abstracts: Acarbose for diabetes mellitus. Nateglinide for type 2 diabetes. Direct-to-consumer advertisements for Glucophage XR
• Abstracts: Pharmacotherapy for heart failure in patients with renal insufficiency. Ibopamine: a drug that has opposite effects depending on the severity of a patient's disease
• Abstracts: Edema of the bone marrow can cause pain in osteoarthritis and other diseases of bone and joints. The association of bone marrow lesions with pain in knee osteoarthritis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.